0000899243-21-014727.txt : 20210405
0000899243-21-014727.hdr.sgml : 20210405
20210405090611
ACCESSION NUMBER:		0000899243-21-014727
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210402
FILED AS OF DATE:		20210405
DATE AS OF CHANGE:		20210405
REPORTING-OWNER:	
	OWNER DATA:	
		COMPANY CONFORMED NAME:			Buell Jennifer
		CENTRAL INDEX KEY:			0001711184
	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29089
		FILM NUMBER:		21803900
	BUSINESS ADDRESS:	
		BUSINESS PHONE:		781-674-4400
	MAIL ADDRESS:	
		STREET 1:		3 FORBES ROAD
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
ISSUER:		
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AGENUS INC
		CENTRAL INDEX KEY:			0001098972
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				061562417
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231
	BUSINESS ADDRESS:	
		STREET 1:		3 FORBES ROAD
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		781-674-4410
	MAIL ADDRESS:	
		STREET 1:		3 FORBES ROAD
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTIGENICS INC /DE/
		DATE OF NAME CHANGE:	19991115
4
1
doc4.xml
FORM 4 SUBMISSION
    X0306
    4
    2021-04-02
    0
    
        0001098972
        AGENUS INC
        AGEN
    
    
        
            0001711184
            Buell Jennifer
        
        
            C/O AGENUS INC.
            3 FORBES ROAD
            LEXINGTON,
            MA
            02421
            
        
        
            0
            1
            0
            0
            President & COO
        
    
    
        
            
                Common Stock
                
            
            
                2021-04-02
            
            
            
                4
                A
                0
            
            
                
            
            
                
                    80838
                
                
                    2.87
                    
                
                
                    A
                
            
            
                
                    116494
                
            
            
                
                    D
                
            
        
    
    
        All Agenus employees were given the option to receive their 2020 bonus awards in cash or Agenus stock.  Dr. Armen, Dr. Buell and Ms. Klaskin have all chosen to receive their entire 2020 bonus award in Agenus stock rather than cash. The stock issued is fully-vested on the date of issuance, but is subject to a 6-month lockup restriction.
        $2.87 is the fair market value of our Common Stock on April 2, 2021, the stock issuance date.
    
    
    
        /s/Evan D. Kearns, as Attorney-in-Fact for Jennifer Buell
        2021-04-05